CRISPR Therapeutics (CRSP)
(Real Time Quote from BATS)
$53.95 USD
-1.72 (-3.08%)
Updated Feb 8, 2023 12:40 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/21/2023
Time: -- |
12/2022 | $-2.32 | 0.00% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$2.24 per share, beating the Zacks Consensus Estimate of $-2.30 per share. This reflects a positive earnings surprise of 2.61%. Look out for CRSP's next earnings release expected on February 21, 2023. For the next earning release, we expect the company to report earnings of -$2.32 per share, reflecting a year-over-year decrease of 26.09%.
Earnings History
Price & Consensus
Zacks News for CRSP
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services